Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functional assays for screening GPCR targets.

William Thomsen1, John Frazer, David Unett

  • 1Arena Pharmaceuticals Inc., San Diego, California 92121, USA. bthomsen@arenapharm.com

Current Opinion in Biotechnology
|November 1, 2005
PubMed
Summary

High-throughput screening assays for G-protein-coupled receptors (GPCRs) are crucial for identifying new drug candidates. Researchers are developing advanced biosensors and imaging techniques for more effective GPCR drug discovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diazepine Agonists of the 5-HT<sub>2C</sub> Receptor with Unprecedented Selectivity: Discovery of Bexicaserin (LP352).

Journal of medicinal chemistry·2025
Same author

Mechanisms of constitutive and agonist-induced 5-HT<sub>2B</sub> internalization, persistent endosomal signaling and paradoxical regulation of agonist pharmacology.

Cellular signalling·2025
Same author

Unique pharmacological properties of etrasimod among S1P receptor modulators.

FEBS open bio·2024
Same author

Variation of Diagnostic Approaches and Treatment Practices for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome Among Pediatric Subspecialists.

The Journal of pediatrics·2022
Same author

Early Presentation of Homozygous Mismatch Repair Deficient Glioblastoma in Teen With Lynch Syndrome: Implications for Treatment and Surveillance.

JCO precision oncology·2022
Same author

Novel (R)-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,n]naphthyridines as potent and selective agonists of the 5-HT<sub>2C</sub> receptor.

Bioorganic & medicinal chemistry letters·2021

Area of Science:

  • Pharmacology
  • Biotechnology
  • Drug Discovery

Background:

  • G-protein-coupled receptors (GPCRs) represent key targets in pharmaceutical research.
  • Developing efficient high-throughput screening (HTS) assays is essential for identifying novel drug candidates.
  • Current assay methods have limitations that necessitate innovation.

Purpose of the Study:

  • To review the landscape of functional G-protein-coupled receptor (GPCR) assays for drug discovery.
  • To highlight the advantages and disadvantages of existing fluorescence and chemiluminescence assay kits.
  • To introduce emerging biosensor and high-content imaging technologies for GPCR screening.

Main Methods:

  • Literature review of commercially available GPCR functional assay kits.

Related Experiment Videos

  • Analysis of fluorescence and chemiluminescence detection methods.
  • Exploration of novel GPCR biosensors and high-content imaging platforms.

    • Main Results:

    • Various assay kits offer convenient but have distinct pros and cons.
    • New biosensor technologies enable functional GPCR screening in living cells.
    • High-content imaging provides advanced capabilities for cellular assays.

    Conclusions:

    • The evolution of GPCR assays is critical for efficient drug discovery.
    • Emerging technologies promise more sophisticated and effective screening methods.
    • Continued development of GPCR assays will accelerate the identification of novel therapeutics.